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Objective: To compare the outcomes of total aortic arch transposition (TAAT) vs hemi-aortic arch transposition (HAAT)
for hybrid aortic arch repair.
Methods: A systematic search was performed using PubMed between November 1998 and May 2010 by two independent
observers. Studies included reporting on patients treated by TAAT or HAAT and stent grafting in a proximal landing
zone 0 or 1 by Ishimaru, respectively. Further articles were identified by following MEDLINE links, by cross-referencing
from the reference lists, and by following citations for these studies. Case reports and case series of less than five patients
were excluded. Primary technical and initial clinical success, perioperative, and late morbidity and mortality were
extracted per study and were meta-analyzed.
Results: Fourteen studies were included in the statistical analysis. The number of reported patients totaled 130 for
TAAT/zone 0 and 131 for HAAT/zone 1. The primary technical success rate was significantly higher in zone 0 than 1
(95% vs 83%; odds ratio [OR], 4.0; 95% confidence interval [CI], 1.47-10.88; P  .0069), due to significantly higher
primary type I or III endoleak rates in zone 1 (15.48% vs 3.97%; P  .0050). Reintervention rates were significantly
higher in zone 1 (25.81% vs 12.00%; P .0321). Initial clinical success rates were comparable between zone 0 and 1 (88%
vs 85%; OR, 1.35; 95% CI, 0.61-3.02; P  .5354). In-hospital mortality was higher in zone 0 than 1 (8.46% vs 4.58%;
P  .2212).
Conclusion: The more invasive TAAT allows a better landing zone at the cost of higher perioperative mortality, therefore,
patient selection is crucial. ( J Vasc Surg 2011;54:1182-6.)
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tOpen aortic arch repair necessitating deep hypothermia
and circulatory arrest is offered to elderly and comorbid
patients only with a considerable risk of mortality and
morbidity.1,2 Since the first report of supra-aortic vessel
transposition before stent grafting of the aortic arch by
Buth et al3 in 1998, several case reports and small series
have proven the feasibility and safety of arch vessel revascu-
larization followed by endovascular repair into zone 0 and
1 (Ishimaru classification) of the aorta, as a less invasive
alternative to conventional open treatment in high-risk
patients.3-20
Yet, there are conflicting results as to the outcomes of
open-endovascular hybrid aortic arch repair (HAAR) with
respect to the proximal landing zone. In 2006, Bergeron et
al15 argued that total aortic arch transposition (TAAT) may
be safer than the less invasive hemi-aortic arch transposition
(HAAT), allowing a better landing zone. Yet, that study
was limited by the relatively small sample size. The purpose
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1182f this first systematic review was to compare the outcomes
f TAAT vs HAAT for HAAR in large patient cohorts and
hus to enable safer conclusions.
ETHODS
Literature search. A systematic search was performed
sing PubMed between November 1998 and May 2010.
itles and abstracts were screened by two reviewers inde-
endently to identify potentially relevant articles. Further
rticles were identified by following MEDLINE links, by
ross-referencing from the reference lists, and by following
itations for these studies.
Study eligibility. Studies were included reporting on
atients treated by HAAR and with a proximal landing
one 0 or 1 according to Ishimaru.20 In zone 0, revascu-
arization of the brachiocephalic trunk and left common
arotid artery (LCCA) with or without revascularization of
he left subclavian artery was performed on the patients
rom the ascending aorta via median sternotomy. In zone 1,
ll patients received extra-anatomical revascularization of
he LCCA with or without revascularization of the left
ubclavian artery via carotid-carotid w/carotid-subclavian
ypass. In some articles, patients treated by HAAR were
ot the main, but a subpopulation and no detailed infor-
ation was given of this subgroup. Data were included in
his review if there was a separate description of these
atients or if relevant data could be sufficiently retrieved
rom the article. At least one of the outcome parameters
hat are mortality, stroke, spinal cord injury, endoleaks
ELs) had to be reported. Case reports and case series of less
han five patients were excluded. Studies containing dupli-
ate material were excluded and the ones with the best-
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Volume 54, Number 4 Kotelis et al 1183documented material were included for analysis. Articles
were excluded if aortic arch repair was only by surgical or
endovascular approaches alone or if arch transposition was
performed under circulatory arrest or concomitant coro-
nary artery revascularization.
Data extraction. The following data were extracted
per study: primary technical success, initial clinical success,
endoprosthesis-related complications, neurologic morbid-
ity, mean follow-up period, reinterventions, procedure-
related and total follow-up mortality, and patency of the
transposition reconstructions. Two times, additional data
were gathered by personal communication with the corre-
sponding authors of the studies.15,18 The patient demo-
graphics and risk factors were previously identified by other
studies. All patients were considered to be at high surgical
risk owing to serious comorbidities (American Society of
Anesthesiology III) or previous aortic surgery.
Definitions and statistical analysis. According to the
Ishimaru/Criado classification, zone 0 extends proximal to
the innominate artery and zone 1 involves the ostium of the
LCCA.19,20 ELs were categorized, as previously described
byWhite et al.21 ELs first observed during the perioperative
(30 days) period were defined as primary EL. The defini-
tions of technical and clinical success are according to the
reporting standards for endovascular aortic aneurysm re-
pair.22 Regarding clinical success, no data on an intention-
to-treat basis were available. Clinical success was claimed
for those patients with a type II EL only in the absence of
aneurysm expansion. Primary technical success and initial
clinical success included events that occurred within the
first 24 hours and 30 days after intervention, respectively.
The main endpoints, technical success and clinical suc-
cess, were compared between zone 0 and 1. This study
represents a “per-protocol” analysis, because there were no
“no intention-to-treat” data available. As such, all patients
in zone 0 were treated with TAAT, and all patients in zone
1 were treated with HAAT. SAS software (version 9.1, SAS
Institute, Cary, NC) was used for statistical analysis. The
differences in proportions of success rates were analyzed
using the Fisher exact test. The estimates of the success
rates, the corresponding odds ratios (ORs), and the differ-
ences between success rates were given with the 95% con-
fidence intervals (CIs). Methods for estimation of success
rates and ORs and methods for construction of CIs used
Table I. Indications for HAAR comparing landing zone 0
Landing zone No. of patients
Indication NR Ref VII, XI
XIV, XVII, and XVII
Zone 0 130 44
(% of reported)
Zone 1 131 35
(% of reported)
Total 261 79
(% of reported)
HAAR, Hybrid aortic arch repair; NR, number; PAU-IMH, penetrating ao
Data are further specified in Supplemental Table I.were described in Collett.23 If not otherwise indicated, 9ests used were two-sided and a statistical significance was
ccepted at the 5% level (P  .05).
ESULTS
The initial electronic search yielded 369 articles. After
creening of titles and abstracts, and after additional
earches by hand in accordance with the inclusion criteria,
4 studies were included in our statistical analysis.
Study characteristics. The number of reported pa-
ients totaled 130 for zone 0 and 131 for zone 1. The
ajority of patients (75% for zone 0, 67% for zone 1) were
en with a mean age between 64 and 74 years old. Indi-
ations for treatment were aneurysms in more than half of
he patients, followed by dissections and aortic ulcers in
atients in both zone 0 and zone 1 (Table I). The urgency
f the procedures is reported only by a few authors for zone
and zone 1 separately. An overall mean of 17% patients in
one 0 and 26% in zone 1 were treated under urgent or
mergent conditions. Slightly more authors preferred a
imultaneous surgical/endovascular hybrid repair over a
wo-stage repair. Weighted average follow-up was 21.6
onths (minimum 9 months, maximum 37 months).
Technical success. The outcome parameters of the
ndividual studies and cumulative comparative data be-
ween zone 0 and 1 with P values are presented in Table II.
he primary technical success rate was significantly higher
n zone 0 than in zone 1 (95% vs 83%; OR, 4.0; 95% CI,
.47-10.88; P  .0069). In fact, every study but one
eported higher technical success rates after TAAT than
AAT and stent grafting. In zone 0, technical success rates
ange between 80% and 100%. In zone 1, the rates range
etween 67% and 100%. The most common reason for
echnical failure were primary type I or III ELs, which
ccurred in four patients in zone 0 and 13 patients in zone
(3.97% vs 15.48%; P  .0050). In some series, type I or
II EL rates were observed in up to 20% of patients in zone
and 33% of patients in zone 1. Type II ELs occurred in
0.00% of the patients in zone 0 vs 12.90% of the patients
n zone 1. Open repair was required in a patient after TAAT
nd stent grafting who had a Stanford type A dissection, as
ell as in a patient in zone 1 developing stent collapse that
ould not be resolved by endovascular means.
Clinical success. Initial clinical success rates were
omparable between zone 0 and 1 (88% vs 85%; OR, 1.35;
1
,
Aneurysm Dissection PAU-IMH Other Total
59 19 8 0 86
69 22 9 0 100
51 26 17 2 96
53 32 19 2 100
110 45 25 2 182
60 25 14 1 100
lcer-intramural hematoma; Ref, reference.and
, XIII
I
rtic u5% CI, 0.61-3.02; P  .5354). Three studies reported
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October 20111184 Kotelis et alhigher clinical success rates in zone 0, while three studies
reported higher rates in zone 1. In the TAAT group,
clinical success rates ranged between 79% and 100%. In the
HAAT group, clinical success was achieved in between 67%
and 100% of patients. In-hospital mortality was twice as
high in zone 0 (11 patients) than in zone 1 (six patients;
8.46% vs 4.58%; P  .2212). Causes of perioperative mor-
tality are listed in Table III. Mortality was cardiac-related in
the majority of the patients in zone 0. In-hospital mortality
was observed in up to 15% of the patients in zone 0 in some
series, while five centers reported 0% in-hospital mortality.
In the zone 1 group, mortality rates range between 0% and
25%. Reintervention rates were significantly higher after
Table IIa. Complications after HAAR comparing landing
Landing zone No. of patients Stroke
Not reported (zone 0/I) 4/11
Zone 0 130 4
(% of reported) 3.2
Zone 1 (% of reported) 131 5
(% of reported) 4.2
Total 261 9
(% of reported) 3.7
P value .74
Odds ratio 0.75
95% confidence interval 0.20-2.88
HAAR, Hybrid aortic arch repair.
Data are further specified in Supplemental Table IIa.
Table IIb. Outcomes after HAAR comparing landing zon
Landing zone
No. of
patients
Primary technical
success
Not reported (zone 0/I) 4/47
Zone 0 130 120
(% of reported) 95.2
Zone 1 131 70
(% of reported) 83.3
Total 261 190
(% of reported) 90.5
P value 0.0069
Odds ratio 4.0
95% confidence interval 1.47-10.88
HAAR, Hybrid aortic arch repair; N/A, not applicable.
Data are further specified in Supplemental Table IIb.
Table III. In-hospital mortality
Causes of death
Zone 0
No. (%)
Zone 1
No. (%)
Cardiac related 4 (3) 1 (1)
Stent-graft related 1 (1) 3 (2)
Stroke 2 (1.5) 0
Pulmonary 1 (1) 0
Not specified 3 (2) 2 (1.5)
Total 11 (8.5) 6 (4.5)HAAT and stent grafting than TAAT (25.81% vs 12.00%; c .0321). In some centers, reinterventions were neces-
ary in up to 56% of the patients in zone 0 and 36% of the
atients in zone 1.
Aortic-related mortality after hospital discharge was
eported by 10 of the 14 studies and was observed in two
atients in zone 1 and no patients in zone 0 (3.39% vs
.00%; P  .1552). Given the short follow-up of most
tudies, no midterm clinical success rates could be esti-
ated. All arterial reconstructions were patent during
ollow-up in both groups.
Neurologic morbidity. Strokes occurred equally in
oth zones. Four strokes (two major and two minor;
.17%; P  .7441) occurred in zone 0 and five strokes
ccurred in zone 1 (two major and three minor; 4.17%).
n the other hand, the paraplegia rate was higher in zone 1
ompared to zone 0 (3 vs 1 event; 0.77% vs 2.29%; P 
6221). In fact, paraplegia was transient in zone 0, while the
hree patients who were paraplegic in zone 1 made no or
nly partial recovery.
ISCUSSION
The results of this meta-analysis indicate that the less
nvasive HAAT for endovascular aortic arch repair is asso-
e 0 and 1
Spinal cord
injury
Type I or type III
endoleak Type II endoleak
0/0 4/47 30/69
1 5 10
0.8 4 10
3 13 8
2.3 15.5 12.9
4 18 18
1.5 8.6 11.1
.62 .0050 .61
0.33 4.43 0.75
0.03-3.22 1.52-12.95 0.28-2.02
nd 1
interventions
In-hospital
mortality
Initial clinical
success
Late
mortality
30/69 0/0 4/47 40/72
12 11 111 0
12 8.5 88.1 0
16 6 71 2
25.8 4.6 84.5 3.4
28 17 182 2
17.3 6.5 86.7 1.3
0.0321 0.22 0.53 0.16
2.55 1.93 1.35 N/A
1.11-5.84 0.69-5.37 0.61-3.02 N/Azone 0 a
Reiated with a significantly higher primary technical failure
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Volume 54, Number 4 Kotelis et al 1185rate compared to TAAT, but that short-term clinical suc-
cess rates are equally satisfactory by both methods.
HAAR has been shown to be a safe alternative to
conventional open repair and may even have a lower mor-
tality for high-risk patients, as recently suggested by
Milewski et al.24 Avoiding sternotomy, as with HAAT,
seems to be the most luring alternative in often highly
comorbid patients. Yet, this meta-analysis shows a signifi-
cantly lower primary technical success rate of stent graft
deployment into zone 1 of the aortic arch compared to
TAAT and endografting in zone 0. The reasons for this
include shorter landing zones (LZs) obtained by rerouting
blood flow only to the LCCA. The LZ in these cases rarely
exceeds 20 mm, in contrast to 30 mm of LZ that can easily
be reached by TAAT. Shorter LZs along with the steeper
angulation of the aortic arch in zone 1 may lead to a poorer
anchoring of the stent graft and thus significantly higher
type I and III EL rates in zone 1 compared to zone 0, as
were seen in this study.
As a consequence of the higher type I and III EL rate in
zone 1, this meta-analysis shows a significantly higher rein-
tervention rate in zone 1 than zone 0. Thus, the observed
catch-up of the zone 1 group in terms of short-term clinical
success in this study is caused by higher reintervention rates
in zone 1 on the one hand, and on the other hand, with the
higher in-hospital mortality rate in zone 0 compared to
zone 1. Certainly, TAAT is associated with significantly
greater surgical trauma resulting in higher perioperative
mortality in this often very comorbid patient group. This is
demonstrated by the higher cardiac-related mortality in
zone 0 as opposed to zone 1 patients in this study. The
higher mortality rates in zone 0 were seen despite the
insignificantly lower proportion of emergency procedures
in this group, which are associated with increased periop-
erative mortality. Yet, there might be a selection bias be-
tween the groups, since TAAT is often reserved for fitter
patients, as shown by our group on the basis of log Euro-
score.5 Thus, the difference in perioperative mortality
might have been even bigger between the groups, were the
patients at the same high risk.
Mortality was also stroke-associated in two patients in
the TAAT group. Proximal extent of repair was significantly
associated with a higher incidence of strokes in the past.25
This is true when comparing stent graft anchorage into the
aortic arch (zones 0-2) vs the descending thoracic aorta
(zones 3-4) and is due to lengthy wire manipulation within
the aortic arch. Yet, we could not identify any difference in
the incidence or severity of strokes with a more proximal
stent graft anchorage between zones 0 and 1.
Paraplegia rates were not significantly different be-
tween zones 0 and 1 either, but the trend observed might
be informative. In fact, not only the incidence but also the
severity of paraplegia was higher followingHAAT vs TAAT
and stent grafting. A possible explanation for this may be
the insignificantly higher proportion of long segment aortic
disease (eg, type B dissections) in the zone 1 group, which
require long segment aortic coverage and are thus associ-
ated with an increased risk of paraplegia.26Themain limitation to this study is the lack of anatomic
ata of the two cohorts, so the results and conclusions must
e cautiously interpreted in this context.
The heterogeneity of aortic pathologies in both groups,
long with the different proportions of emergency proce-
ures, the lack of use of risk stratifications systems by most
uthors, and, of course, the retrospective design of this
tudy are major limitations of these results. In the future,
he use of uniform reporting standards should be manda-
ory, in order to draw more robust conclusions from such
eta-analyses.
ONCLUSIONS
Hemi-arch transposition for hybrid aortic arch repair is
ssociated with significantly higher primary technical failure
nd reintervention rates compared to total-arch transposi-
ion, but with equally satisfactory initial clinical success
ates. The more invasive total-arch transposition allows a
etter LZ at the cost of higher perioperative mortality,
herefore, making patient selection crucial.
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t www.jvascsurg.org.INVITED COMMENTARYWei Zhou, MD, Stanford, Calif
Thoracic aortic pathology involving supra-aortic branches
poses a significant therapeutic dilemma for high-risk patients as
endovascular therapy alone is not feasible using currently available
thoracic endoprothesis. Consequently, a hybrid approach involv-
ing surgical supra-aortic vessel bypass to create an adequate landing
zone followed by endovascular stent grafting has been adopted by
many centers. However, the techniques for supra-aortic trunk
bypass and the interventional outcomes vary significantly. In this
collated review, Dr Kotelis compared the outcomes of two adjunc-
tive surgical techniques, total aortic arch transposition for patients
with zone 0 aortic diseases, and hemi-aortic arch transposition for
patients with zone 1 aortic diseases. Extracting from a total of 14
case series that met inclusion criteria, Dr Kotelis and coauthors
demonstrated that although both adjunctive surgical techniques
for hybrid aortic arch repair had an equally satisfactory initial
clinical success rate, the less invasive hemi-aortic arch transposition
was associated with significantly higher primary technical failureransposition allowed a better landing zone at the cost of higher
erioperative mortality.
Dr Kotelis should be commended on the effort of taking on
his difficult task by examining the existing scientific evidence.
here is a paucity of well-conducted studies on this challenging
linical disease. As demonstrated by the author, the two groups of
atients were extremely heterogeneous, including a mix and un-
atched population of aortic aneurysm, dissection, and aortic
lcer/intramural hematoma. Additionally, two patient cohorts
ad different extents of aortic involvements. Patients who receive
otal-aortic arch repairs all had zone 0 lesions, while those who
eceived hemi-aortic arch repair all had zone 1 lesions. Anatomic
ata and physiological data of the two cohorts were also not
vailable. Therefore, the results of this collated review should be
nterpreted with caution. Nonetheless, Dr Kotelis’ timely review
n this subject helps to highlight the awareness and management
ifficulty of this challenging clinical dilemma. This article reveals an
pportunity for a new generation of endovascular devices to treat
he aortic pathology involving supra-aortic vessels.
ng aortic ulcer-intramural hematoma; Ref, reference.
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Ref
Aneurysm Dissection PAU-IM
Zone 0 Zone 1 Zone 0 Zone 1 Zone 0 Z
5 8 11 0 7 2
6 3 8 6 9 0
7 NR NR NR NR NR
8 15 0 6 0 5
9 0 19 0 5 0
10 5 8 0 0 0
11 NR NR NR NR NR
12 4 0 1 0 1
13 NR NR NR NR NR
14 NR NR NR NR NR
15 9 5 6 5 0
16 15 0 0 0 0
17 NR NR NR NR NR
18 NR NR NR NR NR
HAAR, Hybrid aortic arch repair; NR, not reported; PAU-IMH, penetratilanding zone 0 and 1
H Other Total
Mean follow-
up (months)one 1 Zone 0 Zone 1 Zone 0 Zone 1
5 0 2 10 25 33.2
0 0 0 9 17 NR
NR NR NR 6 4 29.9
0 0 0 26 0 NR
12 0 0 0 36 37
0 0 0 5 8 14
NR NR NR 7 2 14
0 0 0 6 0 9
NR NR NR 4 11 26.2
NR NR NR 14 12 28
0 0 0 15 10 15
0 0 0 15 0 18
NR NR NR 8 5 16
NR NR NR 5 1 8-18
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October 20111186.e2 Kotelis et alSupplemental Table IIa. Complications after HAAR comparing landing zone 0 and 1
Ref
Strole Spinal cord injury Type I or III endoleak Type II endoleak
Zone 0 (%) Zone 1 (%) Zone 0 (%) Zone1 (%) Zone 0 (%) Zone 1 (%) Zone 0 (%) Zone 1 (%)
5 0/10 2/25 (8) 0/10 1/25 (4) 2/10 (20) 6/25 (24) 3/10 (30) 2/25 (8)
6 0/9 0/17 0/9 1/17 (6) 1/9 (11) 1/17 (6) 5/9 (56) 6/17 (35)
7 1/6 (17) 0/4 1/6 (17) 0/4 0/6 0/4 1/6 (17) 0/4
8 1/26 (4) 0/26 (4) 0/26 (4) 1/26 (4)
9 0/36 0/36 NR NR NR NR
10 0/5 2/8 (25) 0/5 0/8 0/5 0/8 NR NR
11 0/7 0/2 0/7 1/2 (50) 0/7 0/2 NR NR
12 0/6 0/6 0/6 0/6
13 NR NR 0/4 0/11 NR NR NR NR
14 2/14 (14) 0/12 0/14 0/12 1/14 (7) 4/12 (33) NR NR
15 0/15 1/10 (10) 0/15 0/10 1/15 (7) 1/10 (10) 0/15 0/10
16 0/15 0/15 0/15 0/15
17 0/8 0/5 0/8 0/5 0/8 0/5 0/8 0/5
18 0/5 0/1 0/5 0/1 0/5 1/1 (100) 0/5 0/1HAAR, Hybrid aortic arch repair; NR, not reported; Ref, reference.Supplemental Table IIb. Outcomes after HAAR comparing landing zone 0 and 1
Ref
Primary technical success Initial clinical success In-hospital mortality Reintervention Late mortality
Zone 0
(%)
Zone 1
(%)
Zone 0
(%)
Zone 0
(%)
Zone 0
(%)
Zone 1
(%)
Zone 0
(%)
Zone 1
(%)
Zone 0
(%)
Zone 1
(%)
5 8/10 (80) 19/25 (76) 8/10 (80) 19/25 (76) 1/10 (10) 1/25 (4) 5/10 (50) 9/25 (36) NR NR
6 8/9 (89) 16/17 (94) 8/9 (89) 5/17 (94) 1/17 (11) 0/17 5/9 (56) 6/17 (35) 0/9 0/17
7 6/6 (100) 4/4 (100) 5/6 (83) 4/4 (100) 0/6 1/4 (25) 1/6 (17) 0/4 0/6 0/4
8 26/26 (100) 22/26 (85) 4/26 (15) 0/26 NR
9 NR NR 2/36 (5.5) NR NR
10 5/5 (100) 8/8 (100) 5/5 (100) 8/8 (100) 0/5 0/8 NR NR 0/5 0/8
11 7/7 (100) 2/2 (100) 7/7 (100) 2/2 (100) 0/7 0/2 NR NR 0/7 0/2
12 6/6 (100) 6/6 (100) 0/6 0/6 0/6
13 NR NR NR NR 0/4 1/11 (9) NR NR NR NR
14 13/14 (93) 8/12 (66) 11/14 (79) 8/12 (66) 2/14 (14) 0/12 NR NR 0/14 2/12 (17)
15 13/15 (87) 8/10 (80) 13/15 (87) 8/10 (80) 1/15 (7) 1/10 (10) 0/15 0/10 0/15 0/10
16 15/15 (100) 14/15 (93) 1/15 (7) 1/15 (7) 0/15
17 8/8 (100) 5/5 (100) 7/8 (87.5) 5/5 (100) 1/8 (12.5) 0/5 0/8 0/5 0/8 0/5
18 5/5 (100) 0/1 5/5 (100) 1/1 (100) 0/5 0/1 0/5 1/1 (100) 0/5 0/1HAAR, Hybrid aortic arch repair; NR, not reported; Ref, reference.
